DICOT logo

Dicot Pharma AB Stock Price

OM:DICOT Community·SEK 596.8m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

DICOT Share Price Performance

SEK 0.30
0.04 (14.99%)
SEK 0.30
0.04 (14.99%)
Price SEK 0.30

DICOT Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet with slight risk.

4 Risks
0 Rewards

Dicot Pharma AB Key Details

SEK 0

Revenue

SEK 0

Cost of Revenue

SEK 0

Gross Profit

SEK 80.2m

Other Expenses

-SEK 80.2m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Apr 30, 2026
-0.04
0%
0%
0%
View Full Analysis

About DICOT

Founded
2015
Employees
4
CEO
Elin Trampe
WebsiteView website
www.dicotpharma.com

Dicot Pharma AB engages in the development of pharmaceutical products in Sweden. It develops LIB-01 for the treatment of erectile dysfunction and premature ejaculation. The company was formerly known as Dicot AB (publ) and changed its name to Dicot Pharma AB in May 2024. Dicot Pharma AB was incorporated in 2015 and is based in Uppsala, Sweden.

Recent DICOT News & Updates

Is Dicot Pharma (STO:DICOT) In A Good Position To Invest In Growth?

Feb 03
Is Dicot Pharma (STO:DICOT) In A Good Position To Invest In Growth?

Recent updates

No updates